127 related articles for article (PubMed ID: 38606540)
1. Design and synthesis of novel coumarin-benzimidazole hybrids as human galectin-1 inhibitors.
Nerella SG; Alvala R; Kalle AM; Alvala M
Future Med Chem; 2024 Apr; ():. PubMed ID: 38606540
[No Abstract] [Full Text] [Related]
2. Novel benzimidazole-triazole hybrids as apoptosis inducing agents in lung cancer: Design, synthesis,
Sridhar Goud N; Pooladanda V; Muni Chandra K; Lakshmi Soukya PS; Alvala R; Kumar P; Nagaraj C; Dawn Bharath R; Qureshi IA; Godugu C; Alvala M
Bioorg Chem; 2020 Sep; 102():104125. PubMed ID: 32738568
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biological Evaluation of Novel Heterocyclic Imines Linked Coumarin- Thiazole Hybrids as Anticancer Agents.
Goud NS; Ghouse MS; Vishnu J; Pranay J; Alvala R; Talla V; Qureshi IA; Alvala M
Anticancer Agents Med Chem; 2019; 19(4):557-566. PubMed ID: 30734685
[TBL] [Abstract][Full Text] [Related]
4. Coumarin-benzimidazole hybrids: A review of developments in medicinal chemistry.
G AC; Gondru R; Li Y; Banothu J
Eur J Med Chem; 2022 Jan; 227():113921. PubMed ID: 34715585
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of morpholines linked coumarin-triazole hybrids as anticancer agents.
Goud NS; Pooladanda V; Mahammad GS; Jakkula P; Gatreddi S; Qureshi IA; Alvala R; Godugu C; Alvala M
Chem Biol Drug Des; 2019 Sep; 94(5):1919-1929. PubMed ID: 31169963
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of iNOS by Benzimidazole Derivatives: Synthesis, Docking, and Biological Evaluations.
Minhas R; Bansal Y
Med Chem; 2022; 18(5):602-615. PubMed ID: 34579637
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
[TBL] [Abstract][Full Text] [Related]
8. Biological evaluation of novel amidino substituted coumarin-benzazole hybrids as promising therapeutic agents.
Beč A; Racané L; Žonja L; Persoons L; Daelemans D; Starčević K; Vianello R; Hranjec M
RSC Med Chem; 2023 May; 14(5):957-968. PubMed ID: 37252100
[TBL] [Abstract][Full Text] [Related]
9. Cinnamide derived pyrimidine-benzimidazole hybrids as tubulin inhibitors: Synthesis, in silico and cell growth inhibition studies.
Sana S; Reddy VG; Srinivasa Reddy T; Tokala R; Kumar R; Bhargava SK; Shankaraiah N
Bioorg Chem; 2021 May; 110():104765. PubMed ID: 33677248
[TBL] [Abstract][Full Text] [Related]
10. Synthesis,
Goud NS; Kanth Makani VK; Pranay J; Alvala R; Qureshi IA; Kumar P; Bharath RD; Nagaraj C; Yerramsetty S; Pal-Bhadra M; Alvala M
Bioorg Chem; 2020 Apr; 97():103663. PubMed ID: 32106038
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Biomedical Potential and Molecular Docking Analyses of Coumarin-Triazole Hybrids as Tyrosinase Inhibitors: Design, Synthesis, In Vitro Profiling, and In Silico Studies.
Kausar R; Zahoor AF; Tabassum H; Kamal S; Ahmad Bhat M
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675492
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis and Bioactivity Evaluation of Coumarin-BMT Hybrids as New Acetylcholinesterase Inhibitors.
Zeng F; Lu T; Wang J; Nie X; Xiong W; Yin Z; Peng D
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408542
[TBL] [Abstract][Full Text] [Related]
13. Automated Radiosynthesis and Molecular Docking Studies of Coumarin- Triazole Hybrid with fluorine-18: A feasibility study.
Goud NS; Ghouse MS; Nagaraju C; Bharath RD; Alvala M; Kumar P
Curr Radiopharm; 2022; 15(1):40-49. PubMed ID: 33511934
[TBL] [Abstract][Full Text] [Related]
14. Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes.
Maghraby MT; Abou-Ghadir OMF; Abdel-Moty SG; Ali AY; Salem OIA
Bioorg Med Chem; 2020 Apr; 28(7):115403. PubMed ID: 32127262
[TBL] [Abstract][Full Text] [Related]
15.
Kumar S; Ali I; Abbas F; Rana A; Pandey S; Garg M; Kumar D
J Biomol Struct Dyn; 2023 Aug; ():1-23. PubMed ID: 37646177
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
Paul K; Bindal S; Luxami V
Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 1-benzyl-1H-benzimidazoles as galectin-1 mediated anticancer agents.
Goud NS; Ghouse SM; Vishnu J; Komal D; Talla V; Alvala R; Pranay J; Kumar J; Qureshi IA; Alvala M
Bioorg Chem; 2019 Aug; 89():103016. PubMed ID: 31185390
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the Alkaline Phosphatase Inhibition, Anticancer, and Antileishmanial Potential of Coumarin-Triazolothiadiazine Hybrids: Design, Synthesis, and Molecular Docking Analysis.
Ibrar A; Zaib S; Jabeen F; Iqbal J; Saeed A
Arch Pharm (Weinheim); 2016 Jul; 349(7):553-65. PubMed ID: 27214743
[TBL] [Abstract][Full Text] [Related]
19. Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking.
Krstulović L; Leventić M; Rastija V; Starčević K; Jirouš M; Janić I; Karnaš M; Lasić K; Bajić M; Glavaš-Obrovac L
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677600
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, anti-ulcer action and molecular docking evaluation of novel benzimidazole-pyrazole hybrids.
Noor A; Qazi NG; Nadeem H; Khan AU; Paracha RZ; Ali F; Saeed A
Chem Cent J; 2017 Sep; 11(1):85. PubMed ID: 29086868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
